Jane
Booking, charting and billing software for physio, chiro, massage and mental health clinics, nearly self-funded to about US$100M of revenue and valued near $1.8B (currency not stated) in a 2025 share sale.
Techcouver, May 26, 2025; BetaKit, Oct 2024- Valuation
- About $1.8B in a May 2025 secondary led by TCV; reports do not say whether that is Canadian or US dollars. Three times the 2021 price.
- Raised
- Under $10M of outside money for the company itself. The big deals bought existing shares.
- Revenue
- About US$100M a year, reported May 2025. A co-founder said ARR passed $100M in 2024.
- Watch
- Aiming for $250M ARR co-founder Alison Taylor said the climb from $100M to $250M seems more accessible.
- AI
- AI Scribe a charting add-on at $15 per practitioner a month, with 5 free notes on every plan.
- Liquidity
- Two share sales 2021 (JMI bought from founders and staff) and May 2025 (TCV bought from existing holders).
- Hiring
- 28 → 26 remote listings since Oct 10.
Monthly plans per practitioner, plus payments.
Clinics pay a monthly plan: US$59 (Balance, one practitioner, 20 appointments), US$79 (Practice) or US$99 (Thrive), plus a license per extra practitioner. Add-ons include AI Scribe and group telehealth ($15 each per practitioner), insurance billing ($20) and Jane Websites ($59 per clinic). Jane also takes card fees: 2.85% plus $0.25 online, 2.6% plus $0.10 in person. It does not publish a revenue split.
Jane pricing page, checked Nov 3, 2026- 1A large base of small clinicsJane says it supports over 200,000 practitioners, up from 113,000 in early 2023. Press reports put it at about 50,000 clinics in Canada, the US and the UK.Jane via PR Newswire, Nov 19, 2025; Globe and Mail, Jan 2023; Techcouver, May 2025
- 2One system for the whole clinicBooking, scheduling, charting, billing, insurance, payments, telehealth, websites, secure messaging and (in Canada) payroll sit in one product, so switching means moving the clinic's records and money flows.Jane via PR Newswire, Nov 19, 2025
- 3Built on its own revenueMostly self-funded: under $10M raised from outside for the company, per The Globe and Mail. Jane has prioritized profitability from the start, The Logic reports.The Logic, May 26, 2025; BetaKit, Oct 2024
Every round, and what its terms give away.
Jane is private, so there is no share price. What its investors paid, and on what terms, is the closest thing to one.
- $100M
- annual revenue, as of May 26
- 800
- employees, as reported
Reported to prioritize profitability; no profit figure published.
Techcouver, May 26, 2025; Jane careers page, Nov 2026- May 29Secondary sale (2025)Led by TCV$500M plus, at about $1.8B, with JMI Equity and Tidemark. Bought from existing holders; no new money for Jane. The reports we opened do not say which currency, so we show no US dollar figure.Canadian Lawyer, May 2025; BetaKit and The Logic, May 26, 2025
- Jan 11Credit line (debt)Led by CIBC Innovation Banking$2M growth credit line, currency not stated. Date is the announcement date.Techcouver, Jan 11, 2019
- Down round or flat round?No. The 2025 price of about $1.8B is roughly three times the 2021 JMI price of over $600M.BetaKit, May 26, 2025Clear
- How much of the company the last round soldAbout 28% by our math ($500M of $1.8B), all existing shares. Jane issued no new stock, so holders were not diluted.The Logic, May 26, 2025Clear
- Time since the last raiseAbout 17 months since May 2025. Jane has barely raised new money at all, so time since a raise says little about cash.Canadian Lawyer, May 2025Clear
- Structured or unusual termsNone reported. Jane is Canadian, so there is no US Form D to check, and terms were not disclosed.Canadian Lawyer, May 2025; searched Nov 3, 2026Open
- Who led the last roundTCV, a new outside investor, with existing backer JMI Equity and newcomer Tidemark.Foley, Jul 31, 2025; BetaKit, May 2025Clear
- Tender offers or secondary sales for staffYes, at least once. The Globe and Mail says 2021 JMI buyers bought from founders and employees. The 2025 deal bought from existing holders; whether staff could sell was not confirmed in pages we opened.The Globe and Mail, Jan 9, 2023; Logic, May 2025Clear
- Layoffs in the last 12 monthsNone found in news searches. Headcount grew from about 550 (Oct 2024) to more than 800 on the careers page.Jane careers page, checked Nov 3, 2026; BetaKit, Oct 2024Clear
Clear: checked, nothing found. Flag: found, with the source. Open: could not be checked.
What the record says, and what we think it means.
The fact is the source's. The read, in italics, is ours.
- 01Good
Investors bought out early holders at 3x.
Canadian Lawyer, May 2025; The Logic, May 2025In May 2025 TCV led a $500M plus share purchase at about $1.8B, with JMI Equity and Tidemark. The company issued no new shares.
Early holders got cash at a much higher price. Whether staff could sell in 2025 was not reported in what we read; check your own option terms.
- 02Neutral
JMI bought in 2021 at over $600M.
The Globe and Mail, Jan 9, 2023JMI Equity bought more than $100M of shares from founders and employees in 2021, at over $600M, about ten times projected revenue. Pender Ventures also bought.
Jane has used secondaries, not new money, to give early holders cash. Expect that pattern to repeat before any IPO.
- 03Good
Revenue grew fast for a self-funded firm.
Globe and Mail, Jan 2023; BetaKit, Oct 2024; Techcouver, May 2025About $60M a year in early 2023, then $100M ARR in 2024, then close to US$100M of annual revenue reported in May 2025.
Strong growth without venture money is rare. Growth since mid 2025 has not been published.
- 04Neutral
Run by its two co-founders.
BetaKit, Jan 30, 2025; Oct 2024Alison Taylor and Trevor Johnston started Jane as a side project and both lead it; BetaKit calls each co-CEO.
Founder-led and closely held. Strategy is unlikely to swing with investor pressure.
- 05Good
Remote-first across Canada, the US and UK.
Jane careers page, checked Nov 3, 2026The careers page says staff can live and work anywhere in Canada and the US, with UK staff too, and work abroad temporarily. More than 800 people.
Good reach for remote applicants in those three countries. Check each posting for location rules.
- 06Neutral
Pushing into UK private clinics.
Health Tech Digital, Jul 17, 2026Jane says over 1,200 UK clinics use it and UK data is stored in UK data centres. It launched AI Scribe there in July 2026 at 15 pounds a month.
The UK is a second home market. Growth there depends on beating local rivals.
- 07Neutral
Adding payroll and a patient app.
Jane via PR Newswire, Nov 19, 2025The November 2025 release added Jane Payroll for Canadian clinics, a client mobile app, secure messaging and an AI website builder.
More products per clinic can raise revenue per customer, and make Jane harder to leave.
- 08Watch
Deal figures mix currencies.
Techcouver, May 26, 2025; BetaKit, May 2025Reports give revenue in US dollars but the $500M deal and $1.8B valuation with no currency label. Jane did not comment.
Until a primary source says which currency, treat $1.8B as the reported figure only. In Canadian dollars it would be about US$1.3B.
Engineering is paid 14% under market.
We save every company's roles, pay by team and level, AI share and churn every day, so each month this page can say more. Sparklines use their own scale.
Can AI agents do business with Jane?
We checked the agent payment programs, developer docs and site rules an AI assistant would meet.
Partly open. A partner API with webhooks and an llms.txt, but no MCP server, and the docs block crawlers.
Still Remote read- YesAn API outside software can useThe Jane Developer Platform lets approved partners build Jane Extensions, with OAuth plus PKCE, practitioner consent and date-based versions. It covers patients, appointments, charts, medications and webhooks.Jane developer docs, updated Sep 4, 2026
- Not foundAn MCP server agents can callNo MCP server in Jane's developer docs or announcements; the docs index has no mention of MCP.developers.jane.app/llms.txt, checked Nov 3, 2026
- MixedSite and docs AI tools can readjane.app/llms.txt returns 404. The developer site has one, about 8,800 characters, listing every API page.checked Nov 3, 2026
- MixedLets AI crawlers read its sitejane.app names no AI bots but sets Content-Signal ai-train=no, search=yes, ai-input=yes. developers.jane.app robots.txt disallows everything for all crawlers.jane.app and developers.jane.app robots.txt, checked Nov 3, 2026
- YesIts own AI toolsAI Scribe drafts chart notes from a recorded or dictated session for the practitioner to review and sign. Jane says data is never used to train models.Jane AI Scribe page, checked Nov 3, 2026
Where Jane puts AI to work.
- 1Built its scribe on ClaudeJane built Voice-to-Chart (now AI Scribe) on Anthropic's Claude models hosted on AWS Bedrock, after first trying Azure, per an AWS-sponsored BetaKit article.BetaKit (sponsored by AWS), Jan 30, 2025
- 2An in-house AI teamJane says AI Scribe is built in-house, and BetaKit reports a dedicated AI team led by Raj Paul. Jane claims charting time falls up to 50%, based on its Jul to Dec 2025 data.Jane AI Scribe page, Nov 2026; BetaKit, Jan 2025
Fewer listings than on Sep 7, led by engineering.
The signals, and which way they push.
- TailwindClinicians want less paperwork.
A Great Ormond Street pilot reported in coverage cut documentation time 51.7% per clinician; Jane sells AI Scribe in Canada, the US and UK.
- TailwindThe user base keeps growing.
113,000 practitioners in early 2023, over 190,000 in Jan 2025, over 200,000 by Nov 2025.
- HeadwindRivals have buyout money.
Vista Equity took SimplePractice's parent EngageSmart private for about $4.0B in Jan 2024, a big rival in therapy practice software.
- TailwindThe US is the top priority.
BetaKit reports Jane is expanding into new regions with the US as its top priority; its US prices are in US dollars.
Where Jane ends up, if we had to bet.
Our calls, not facts. Each one is tied to something that already happened, so you can judge the reasoning.
- 1
Jane lists on a stock exchange by 2031.
Long shot 16%IPOIt has run secondaries twice instead of listing, and has little need for cash. No filing or IPO plan has been reported.
The Logic, May 2025 - 2
Jane is sold to a larger company or buyout firm by 2031.
Long shot 16%M&AThe co-founders still run it and took a growth investor in 2025, not a buyer. Rivals like EngageSmart went to private equity, so the option exists.
Canadian Lawyer, May 2025; Vista, Jan 2024 - 3
Jane passes $250M of ARR by 2031.
Coin flip 50%RevenueIt went from about $60M a year in early 2023 to $100M ARR in 2024. Payroll, payments and AI add-ons give it more to sell per clinic.
BetaKit, Oct 2024; Globe and Mail, Jan 2023 - 4
Most Jane practitioners use an AI tool to write notes.
Likely 72%AIEvery plan already gets five free AI Scribe notes a month. Clinicians report large time savings in pilots.
Jane pricing page, Nov 2026; Health Tech Digital, Jul 2026 - 5
Jane is the leading allied health clinic system in the US by 2031.
Coin flip 50%CompetitionIt is Canadian-born and now pushing into the US and UK. US rivals such as SimplePractice have deep-pocketed owners.
BetaKit, Jan 2025; Vista, Jan 2024
Read by the Still Remote research agent on November 4, 2026 from the sources linked on this page. Facts and scenarios only, not investment advice.